19-33204646-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002333.4(LRP3):āc.269A>Gā(p.Asn90Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000104 in 1,604,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., cov: 33)
Exomes š: 0.000099 ( 0 hom. )
Consequence
LRP3
NM_002333.4 missense
NM_002333.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.23
Genes affected
LRP3 (HGNC:6695): (LDL receptor related protein 3) Involved in negative regulation of fat cell differentiation; positive regulation of osteoblast differentiation; and regulation of gene expression. Predicted to be located in clathrin-coated pit. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.08348647).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRP3 | NM_002333.4 | c.269A>G | p.Asn90Ser | missense_variant | 4/7 | ENST00000253193.9 | NP_002324.2 | |
LRP3 | XM_005258945.2 | c.269A>G | p.Asn90Ser | missense_variant | 4/7 | XP_005259002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRP3 | ENST00000253193.9 | c.269A>G | p.Asn90Ser | missense_variant | 4/7 | 1 | NM_002333.4 | ENSP00000253193.6 | ||
LRP3 | ENST00000592484.5 | c.23A>G | p.Asn8Ser | missense_variant | 4/5 | 4 | ENSP00000476735.1 | |||
LRP3 | ENST00000590275.1 | n.190A>G | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
LRP3 | ENST00000590278.1 | n.777A>G | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152008Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
23
AN:
152008
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000131 AC: 32AN: 244110Hom.: 0 AF XY: 0.000121 AC XY: 16AN XY: 132562
GnomAD3 exomes
AF:
AC:
32
AN:
244110
Hom.:
AF XY:
AC XY:
16
AN XY:
132562
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000991 AC: 144AN: 1452874Hom.: 0 Cov.: 31 AF XY: 0.000102 AC XY: 74AN XY: 722818
GnomAD4 exome
AF:
AC:
144
AN:
1452874
Hom.:
Cov.:
31
AF XY:
AC XY:
74
AN XY:
722818
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152008Hom.: 0 Cov.: 33 AF XY: 0.000202 AC XY: 15AN XY: 74238
GnomAD4 genome
AF:
AC:
23
AN:
152008
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
74238
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
6
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.269A>G (p.N90S) alteration is located in exon 4 (coding exon 4) of the LRP3 gene. This alteration results from a A to G substitution at nucleotide position 269, causing the asparagine (N) at amino acid position 90 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
T;T
Polyphen
0.28
.;B
Vest4
0.34
MVP
MPC
0.26
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at